| Comparison of Roche Cell-Free DNA collection Tubes® to Streck Cell-Free DNA BCT® s for sample stability using healthy volunteers S Parackal, D Zou, R Day, M Black, P Guilford Practical Laboratory Medicine 16, e00125, 2019 | 30 | 2019 |
| ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma ER Jackson, RJ Duchatel, DE Staudt, ML Persson, A Mannan, S Yadavilli, ... Cancer research 83 (14), 2421-2437, 2023 | 21 | 2023 |
| Circulating tumor DNA is a sensitive marker for routine monitoring of treatment response in advanced colorectal cancer D Zou, R Day, JA Cocadiz, S Parackal, W Mitchell, MA Black, B Lawrence, ... Carcinogenesis 41 (11), 1507-1517, 2020 | 18 | 2020 |
| Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities CX Sun, P Daniel, G Bradshaw, H Shi, M Loi, N Chew, S Parackal, V Tsui, ... Cancer cell 41 (4), 660-677. e7, 2023 | 12 | 2023 |
| Atypical teratoid rhabdoid tumours are susceptible to panobinostat-mediated differentiation therapy WC Chong, WSN Jayasekara, VG Vaghjiani, S Parackal, C Sun, ... Cancers 13 (20), 5145, 2021 | 4 | 2021 |
| PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma RJ Duchatel, ER Jackson, SG Parackal, D Kiltschewskij, IJ Findlay, ... The Journal of Clinical Investigation 134 (6), 2024 | 2 | 2024 |
| EXTH-36. COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL … E Jackson, R Duchatel, D Staudt, M Persson, A Mannan, S Yadavilli, ... Neuro-Oncology 25 (Supplement_5), v232-v232, 2023 | | 2023 |
| EXTH-31. EXPLOITING THE GENETIC DEPENDENCY ON PI3K/MTOR SIGNALING FOR THE TREATMENT OF H3-ALTERED DIFFUSE MIDLINE GLIOMA R Duchatel, E Jackson, S Parackal, C Sun, P Daniel, A Mannan, I Findlay, ... Neuro-Oncology 25 (Supplement_5), v230-v231, 2023 | | 2023 |
| SYST-15 GENERATION AND MULTI-DIMENSIONAL PROFILING OF A CHILDHOOD CANCER CELL LINE ATLAS DEFINES NEW THERAPEUTIC OPPORTUNITIES P Daniel, CX Sun, G Bradshaw, H Shi, M Loi, N Chew, S Parackal, V Tsui, ... Neuro-Oncology Advances 5 (Supplement_3), iii30-iii30, 2023 | | 2023 |
| BIOL-01. GENERATION AND MULTI-OMICS CHARACTERIZATION OF 203 PEDIATRIC CNS TUMOUR MODELS REVEALS NEW THERAPEUTIC VULNERABILITIES C Sun, P Daniel, N Chew, H Shi, M Loi, S Parackal, M Koptyra, ... Neuro-Oncology 25 (Suppl 1), i5, 2023 | | 2023 |
| EXTH-12. PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA E Jackson, R Duchatel, M Persson, A Mannan, S Yadavilli, S Parackal, ... Neuro-Oncology 24 (Supplement_7), vii211-vii211, 2022 | | 2022 |
| DIPG-07. Preclinical and case study results underpinning the phase II clinical trial testing the combination of ONC201 and paxalisib for the treatment of patients with diffuse … MD Dun, ER Jackson, RJ Duchatel, ML Persson, A Mannan, S Yadavilli, ... Neuro-Oncology 24 (Supplement_1), i18-i19, 2022 | | 2022 |
| MODL-17. The Childhood Brain Cancer Cell Line Atlas: A Resource for Biomarker Identification and Therapeutic Development P Daniel, C Sun, M Koptyra, C Drinkwater, N Chew, G Bradshaw, M Loi, ... Neuro-Oncology 24 (Supplement_1), i172-i172, 2022 | | 2022 |
| Combination of paxalisib and ONC201 for the treatment of diffuse intrinsic pontine glioma. E Jackson, R Duchatel, A Mannan, S Yadavilli, M Persson, P Kearney, ... Asia-Pacific Journal of Clinical Oncology, 2021 | | 2021 |
| Functional genomics pipeline reveals therapeutic dependencies in diffuse intrinsic pontine glioma S Parackal, G Bradshaw, C Sun, WC Chong, P Daniel, S Jayasekara, ... Cancer Research 81 (13_Supplement), 3029-3029, 2021 | | 2021 |
| MODL-21. INTEGRATIVE APPROACHES IN FUNCTIONAL GENOMICS TO IDENTIFY GENETIC DEPENDENCIES IN PEDIATRIC BRAIN CANCER C Sun, C Drinkwater, D Sooraj, G Bradshaw, C Shi, D Fernando, ... Neuro-Oncology 22 (Suppl 3), iii415, 2020 | | 2020 |
| DIPG-18. IDENTIFICATION OF TARGETABLE PATHWAY DEPENDENCIES IN DIFFUSE INTRINSIC PONTINE GLIOMA S Parackal, WC Chong, G Bradshaw, C Sun, P Daniel, E Roussel, ... Neuro-Oncology 22 (Supplement_3), iii290-iii290, 2020 | | 2020 |
| The Development of Circulating Tumour DNA as a Clinical Surveillance Tool for New Zealand Breast Cancer Patients SG Parackal University of Otago, 2018 | | 2018 |
| Identification of Targetable Pathway Dependencies in Diffuse Midline Glioma SG PARACKAL Monash University, 0 | | |
